Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Alcon Inc
(NY:
ALC
)
75.63
+0.97 (+1.30%)
Official Closing Price
Updated: 7:00 PM EST, Nov 30, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Alcon Inc
< Previous
1
2
Next >
Alcon Reports Third Quarter 2023 Results
November 14, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023
October 30, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia
October 10, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Inc. (NYSE: ALC) Highlighted for Surprising Price Action
August 17, 2023
Via
Investor Brand Network
Cataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence
September 09, 2023
From
Alcon Inc. Corporate
Via
Business Wire
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030
September 08, 2023
EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams
September 06, 2023
From
Alcon Inc. Corporate
Via
Business Wire
Alcon Reports Second Quarter 2023 Results
August 15, 2023
From
Alcon Inc. Investors
Via
Business Wire
Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
May 22, 2023
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Alcon Advances Company’s Social Impact Through Global Volunteerism
May 22, 2023
From
Alcon Inc. Corporate
Via
Business Wire
Alcon Reports First Quarter 2023 Results
May 09, 2023
From
Alcon Inc. Investors
Via
Business Wire
New Head-to-Head Data Show Clareon Monofocal IOLs and TECNIS Eyhance Monofocal IOLs Provide Similar Range of Vision
May 06, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Announces Results of 2023 Annual General Meeting
May 05, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity
May 01, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Publishes Agenda for 2023 Annual General Meeting
March 29, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon’s “The Lens” Interactive Compliance Training Experience Receives Coveted Anthem Award
March 23, 2023
From
Alcon Inc. Corporate
Via
Business Wire
Alcon to Host 2023 Capital Markets Day
March 20, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon to Debut TOTAL30 for Astigmatism, Dry Eye and Ocular Health Innovations at SECO 2023
March 01, 2023
From
Alcon Inc. Corporate
Via
Business Wire
Alcon Reports Fourth Quarter and Full Year 2022 Results
February 27, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices
February 12, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism
January 05, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon to Present at 2023 Annual J.P. Morgan Healthcare Conference
December 28, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Prices US$1.3 Billion Senior Notes Offering
November 29, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
November 22, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Reports Third Quarter 2022 Results
November 15, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon to Celebrate 75 Years of Brilliance and Showcase Contact Lens Innovations at #Academy22
October 26, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022
September 29, 2022
From
Alcon Inc. Investors
Via
Business Wire
Aerie Pharmaceuticals (NASDAQ: AERI) Enters into Agreement to be Acquired by Alcon (NYSE: ALC) for $770 Million
August 23, 2022
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) is engaged within the research, development and commercialization of ophthalmic therapies for the treatment of
Via
Spotlight Growth
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
August 22, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Reports Second Quarter 2022 Results
August 09, 2022
From
Alcon Inc. Investors
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.